Delivery Order SPE2DB20D1051-SPE2DB25FD8VF
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,902.62, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,878.34, is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The award has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has a ceiling value of $10,883.60 and a period of performance through April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This is a $1,978.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The award has an ultimate completion date of April 8, 2025. No set-aside designation was used. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The award has a ceiling value of $1,920.93 and a period of performance through May 19, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used for diabetes management. The total ceiling value of the contract is $26,496.84, with a period of performance ending on April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a ceiling value of $4,723.08 and a period of performance through May 5, 2025. The contract is not set aside and was awarded on May 2, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $19,099.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The award has an ultimate completion date of January 17, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.54 contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. The award has an ultimate completion date of May 28, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a diabetes treatment medication, with a total ceiling value of $2,667.23 and a completion date of May 13, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...